FDG PET/CT as the Decisive Modality in Distinguishing Clear Cell Sarcoma from Melanoma When Immunohistochemistry Overlaps: A Case Report
Open Access
- 25 March 2026
- journal article
- case report
- Published by Georg Thieme Verlag KG in World Journal of Nuclear Medicine
- Vol. 25 (1) , 93-100
Abstract
Clear cell sarcoma (CCS) and malignant melanoma share overlapping immunohistochemical profiles, particularly SOX10 and HMB45 positivity, making histopathological differentiation challenging. Distinguishing between these entities is clinically essential due to their differing prognoses and therapeutic approaches. This case highlights how fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) contributed decisively to establishing the diagnosis of CCS by following a pathologist-recommended diagnostic algorithm. A 70-year-old male presented with a progressively enlarging left scapular mass. Tru-cut biopsy revealed a malignant neoplasm positive for SOX10 and HMB45, with immunohistochemistry insufficient to differentiate CCS from metastatic melanoma. The pathology report recommended a search for a primary cutaneous melanoma, indicating that in the absence of such a lesion, the diagnosis should favor CCS. Whole-body 18F-FDG PET/CT demonstrated extensive metastatic disease involving the lungs, left adrenal gland, T11 vertebra, scapula, and a large presacral mass. Critically, no hypermetabolic cutaneous, mucosal, or nodal lesions suggestive of a primary melanoma were identified. Comprehensive dermatological evaluation was also negative for suspicious melanocytic lesions. Based on the diagnostic algorithm, histopathology, plus exclusion of a primary melanoma, the PET/CT findings supported the diagnosis of metastatic CCS. This case demonstrates that 18F-FDG PET/CT can serve as a diagnostic tool when histopathology alone is inconclusive. The absence of a primary melanoma on whole-body 18F-FDG PET/CT and clinical examination was the decisive factor favoring CCS over melanoma of unknown primary. This case underscores the limitations of MRI, which often describes CCS as a well-defined, benign-appearing mass, potentially delaying accurate diagnosis. E.A.I. contributed to the conception and design of the case report, performed the literature review, analyzed and interpreted the PET/CT imaging findings, prepared the initial manuscript draft, and completed all subsequent revisions. E.A. provided senior clinical oversight, verified the diagnostic interpretation, contributed to critical revision of the manuscript for important intellectual content, and approved the final version for submission. Both authors read and approved the final manuscript. This case report was conducted in accordance with the ethical standards of our institutional review board. Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. All data generated or analyzed during this case report are included in this published article. Article published online: 25 March 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, IndiaKeywords
This publication has 25 references indexed in Scilit:
- Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma NetworkESMO Open, 2022
- Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exerciseClinical Radiology, 2017
- Metastatic melanomas of unknown primary show better prognosis than those of known primary: A systematic review and meta-analysis of observational studiesJournal of the American Academy of Dermatology, 2015
- Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts)Laboratory Investigation, 2009
- Clear cell sarcoma of tendons and aponeurosesCancer, 2006
- MR findings of clear cell sarcomaClinical Imaging, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- Molecular Diagnosis of Clear Cell SarcomaThe Journal of Molecular Diagnostics, 2002
- MR imaging of clear cell sarcoma (malignant melanoma of the soft parts): a multicenter correlative MRI-pathology study of 21 cases and literature reviewSkeletal Radiology, 2000
- Clear-cell sarcoma of tendons and aponeuroses.An analysis of 21 casesCancer, 1965